PubRank

Michael R Hamblin

Author PubWeight™ 206.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011 6.08
2 Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006 3.93
3 Biphasic dose response in low level light therapy. Dose Response 2009 2.78
4 The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng 2011 2.37
5 Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004 2.12
6 Effect of cell-photosensitizer binding and cell density on microbial photoinactivation. Antimicrob Agents Chemother 2005 1.89
7 Role of low-level laser therapy in neurorehabilitation. PM R 2010 1.79
8 Low-level laser therapy activates NF-kB via generation of reactive oxygen species in mouse embryonic fibroblasts. PLoS One 2011 1.76
9 Photodynamic therapy for localized infections--state of the art. Photodiagnosis Photodyn Ther 2009 1.73
10 Biphasic dose response in low level light therapy - an update. Dose Response 2011 1.69
11 Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother 2006 1.58
12 Targeted photodynamic therapy of established soft-tissue infections in mice. Photochem Photobiol Sci 2004 1.57
13 Use of chitosan bandage to prevent fatal infections developing from highly contaminated wounds in mice. Biomaterials 2006 1.51
14 Photodynamic therapy for Acinetobacter baumannii burn infections in mice. Antimicrob Agents Chemother 2009 1.50
15 Monitoring photodynamic therapy of localized infections by bioluminescence imaging of genetically engineered bacteria. J Photochem Photobiol B 2005 1.50
16 Antimicrobial effects of photodynamic therapy on patients with necrotic pulps and periapical lesion. J Endod 2007 1.46
17 Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players. Lasers Med Sci 2015 1.46
18 Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) 2011 1.45
19 Photodynamic therapy for methicillin-resistant Staphylococcus aureus infection in a mouse skin abrasion model. Lasers Surg Med 2010 1.45
20 Can surgical site infections be treated by photodynamic therapy? Photodiagnosis Photodyn Ther 2010 1.43
21 Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resist Updat 2012 1.42
22 Photodynamic therapy for infections: clinical applications. Lasers Surg Med 2011 1.42
23 Improved cognitive function after transcranial, light-emitting diode treatments in chronic, traumatic brain injury: two case reports. Photomed Laser Surg 2010 1.38
24 Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic Biol Med 2007 1.37
25 Low-level laser therapy for zymosan-induced arthritis in rats: Importance of illumination time. Lasers Surg Med 2007 1.36
26 Low-level light stimulates excisional wound healing in mice. Lasers Surg Med 2007 1.36
27 Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety. Behav Brain Funct 2009 1.35
28 Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg 2013 1.34
29 Antimicrobial photodynamic therapy combined with conventional endodontic treatment to eliminate root canal biofilm infection. Lasers Surg Med 2007 1.33
30 Photodynamic therapy with fullerenes. Photochem Photobiol Sci 2007 1.32
31 Effects of growth phase and extracellular slime on photodynamic inactivation of gram-positive pathogenic bacteria. Antimicrob Agents Chemother 2004 1.31
32 Photodynamic therapy for Staphylococcus aureus infected burn wounds in mice. Photochem Photobiol Sci 2005 1.29
33 Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 2005 1.28
34 Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A 2008 1.23
35 Chitosan preparations for wounds and burns: antimicrobial and wound-healing effects. Expert Rev Anti Infect Ther 2011 1.23
36 Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps. Antimicrob Agents Chemother 2006 1.22
37 Effect of pulsing in low-level light therapy. Lasers Surg Med 2010 1.21
38 Antimicrobial and efflux pump inhibitory activity of caffeoylquinic acids from Artemisia absinthium against gram-positive pathogenic bacteria. PLoS One 2011 1.21
39 Shock wave-mediated molecular delivery into cells. Biochim Biophys Acta 2002 1.19
40 Helicobacter pylori in patients can be killed by visible light. Lasers Surg Med 2005 1.15
41 Comparison of therapeutic effects between pulsed and continuous wave 810-nm wavelength laser irradiation for traumatic brain injury in mice. PLoS One 2011 1.15
42 Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers Surg Med 2012 1.15
43 Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res 2009 1.14
44 Antimicrobial strategies centered around reactive oxygen species--bactericidal antibiotics, photodynamic therapy, and beyond. FEMS Microbiol Rev 2013 1.13
45 Photodynamic inactivation of Acinetobacter baumannii using phenothiazinium dyes: in vitro and in vivo studies. Lasers Surg Med 2010 1.12
46 Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One 2010 1.12
47 Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One 2012 1.12
48 Effect of chitosan acetate bandage on wound healing in infected and noninfected wounds in mice. Wound Repair Regen 2008 1.11
49 Stimulation of anti-tumor immunity by photodynamic therapy. Expert Rev Clin Immunol 2011 1.11
50 Antimicrobial photodynamic inactivation and photodynamic therapy for infections. Methods Mol Biol 2010 1.11
51 Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria. Lasers Surg Med 2012 1.11
52 Deficiency of mannose-binding lectin greatly increases susceptibility to postburn infection with Pseudomonas aeruginosa. J Immunol 2006 1.11
53 Stable synthetic cationic bacteriochlorins as selective antimicrobial photosensitizers. Antimicrob Agents Chemother 2010 1.10
54 Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen. PLoS One 2013 1.10
55 Photochemical activation of TRPA1 channels in neurons and animals. Nat Chem Biol 2013 1.09
56 Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation. Antimicrob Agents Chemother 2008 1.09
57 Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond) 2010 1.09
58 Low-level laser (light) therapy (LLLT) for treatment of hair loss. Lasers Surg Med 2013 1.08
59 Chitosan acetate bandage as a topical antimicrobial dressing for infected burns. Antimicrob Agents Chemother 2008 1.07
60 Blue dye and red light, a dynamic combination for prophylaxis and treatment of cutaneous Candida albicans infections in mice. Antimicrob Agents Chemother 2011 1.07
61 Animal models of external traumatic wound infections. Virulence 2011 1.07
62 Photodynamic therapy with fullerenes in vivo: reality or a dream? Nanomedicine (Lond) 2011 1.07
63 Ultraviolet C irradiation: an alternative antimicrobial approach to localized infections? Expert Rev Anti Infect Ther 2012 1.07
64 Blue light rescues mice from potentially fatal Pseudomonas aeruginosa burn infection: efficacy, safety, and mechanism of action. Antimicrob Agents Chemother 2012 1.07
65 Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol 2012 1.07
66 Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light. Photonics Lasers Med 2012 1.07
67 Dose response effects of 810 nm laser light on mouse primary cortical neurons. Lasers Surg Med 2011 1.06
68 Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study. J Neurotrauma 2014 1.05
69 Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity. Antimicrob Agents Chemother 2007 1.05
70 All you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious disease. Virulence 2011 1.05
71 Low-level laser therapy (808 nm) reduces inflammatory response and oxidative stress in rat tibialis anterior muscle after cryolesion. Lasers Surg Med 2012 1.05
72 Photodynamic inactivation of Bacillus spores, mediated by phenothiazinium dyes. Appl Environ Microbiol 2005 1.02
73 Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions. Photomed Laser Surg 2013 1.02
74 Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond. Curr Opin Pharmacol 2013 1.02
75 Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation. Open Microbiol J 2013 1.01
76 Paradoxical potentiation of methylene blue-mediated antimicrobial photodynamic inactivation by sodium azide: role of ambient oxygen and azide radicals. Free Radic Biol Med 2012 1.00
77 Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease. Photomed Laser Surg 2011 1.00
78 Involvement of skeletal muscle gene regulatory network in susceptibility to wound infection following trauma. PLoS One 2007 1.00
79 Innovative cationic fullerenes as broad-spectrum light-activated antimicrobials. Nanomedicine 2009 1.00
80 Treatment of Helicobacter pylori infection with intra-gastric violet light phototherapy: a pilot clinical trial. Lasers Surg Med 2009 1.00
81 Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro. J Biophotonics 2012 0.99
82 Imidazole metalloporphyrins as photosensitizers for photodynamic therapy: role of molecular charge, central metal and hydroxyl radical production. Cancer Lett 2009 0.99
83 Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 1: normal and chronic wounds: biology, causes, and approaches to care. Adv Skin Wound Care 2012 0.98
84 In vitro photodynamic therapy and quantitative structure-activity relationship studies with stable synthetic near-infrared-absorbing bacteriochlorin photosensitizers. J Med Chem 2010 0.98
85 Low level laser therapy increases angiogenesis in a model of ischemic skin flap in rats mediated by VEGF, HIF-1α and MMP-2. J Photochem Photobiol B 2013 0.98
86 Introduction to experimental and clinical studies using low-level laser (light) therapy (LLLT). Lasers Surg Med 2010 0.97
87 Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 2014 0.97
88 Characterization of plant-derived saponin natural products against Candida albicans. ACS Chem Biol 2010 0.97
89 Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery. Adv Skin Wound Care 2012 0.95
90 Influence of multidrug efflux systems on methylene blue-mediated photodynamic inactivation of Candida albicans. J Antimicrob Chemother 2011 0.95
91 Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna-C(60) contact and effective photodynamic potential. J Mater Chem 2010 0.95
92 Effect of red and near-infrared wavelengths on low-level laser (light) therapy-induced healing of partial-thickness dermal abrasion in mice. Lasers Med Sci 2013 0.95
93 Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: efficacy against bacterial burn infections. Antimicrob Agents Chemother 2011 0.94
94 Ultraviolet-C light for treatment of Candida albicans burn infection in mice. Photochem Photobiol 2011 0.94
95 Strategies to potentiate antimicrobial photoinactivation by overcoming resistant phenotypes. Photochem Photobiol 2012 0.94
96 Far infrared radiation (FIR): its biological effects and medical applications. Photonics Lasers Med 2012 0.94
97 A comparative in vitro photoinactivation study of clinical isolates of multidrug-resistant pathogens. J Infect Chemother 2007 0.93
98 Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A. Cancer Res 2013 0.93
99 Antimicrobial photodynamic therapy to kill Gram-negative bacteria. Recent Pat Antiinfect Drug Discov 2013 0.93
100 Photophysical Characterization of Imidazolium-Substituted Pd(II), In(III), and Zn(II) Porphyrins as Photosensitizers for Photodynamic Therapy. J Photochem Photobiol A Chem 2008 0.92
101 Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships. J Nanomed Nanotechnol 2011 0.92
102 Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev Anti Infect Ther 2014 0.92
103 Down-regulation of glutatione S-transferase α 4 (hGSTA4) in the muscle of thermally injured patients is indicative of susceptibility to bacterial infection. FASEB J 2011 0.92
104 Uptake pathways of anionic and cationic photosensitizers into bacteria. Photochem Photobiol Sci 2009 0.92
105 Drug discovery of antimicrobial photosensitizers using animal models. Curr Pharm Des 2011 0.92
106 Transcranial low level laser (light) therapy for traumatic brain injury. J Biophotonics 2012 0.91
107 Long-term monitoring of live cell proliferation in presence of PVP-Hypericin: a new strategy using ms pulses of LED and the fluorescent dye CFSE. J Microsc 2011 0.91
108 Stable synthetic bacteriochlorins overcome the resistance of melanoma to photodynamic therapy. FASEB J 2010 0.91
109 Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine 2011 0.91
110 Low-level laser (light) therapy increases mitochondrial membrane potential and ATP synthesis in C2C12 myotubes with a peak response at 3-6 h. Photochem Photobiol 2014 0.90
111 Optimal photosensitizers for photodynamic therapy of infections should kill bacteria but spare neutrophils. Photochem Photobiol 2011 0.90
112 Low-level laser therapy for fat layer reduction: a comprehensive review. Lasers Surg Med 2013 0.90
113 Low-level laser therapy (808 nm) contributes to muscle regeneration and prevents fibrosis in rat tibialis anterior muscle after cryolesion. Lasers Med Sci 2012 0.90
114 Synthesis and photodynamic effect of new highly photostable decacationically armed [60]- and [70]fullerene decaiodide monoadducts to target pathogenic bacteria and cancer cells. J Med Chem 2012 0.90
115 Synthesis and properties of benzo[a]phenoxazinium chalcogen analogues as novel broad-spectrum antimicrobial photosensitizers. J Med Chem 2006 0.90
116 Efflux pump inhibitor potentiates antimicrobial photodynamic inactivation of Enterococcus faecalis biofilm. Photochem Photobiol 2010 0.90
117 Burn injury reveals altered phenotype in mannan-binding lectin-deficient mice. J Invest Dermatol 2007 0.89
118 Photodynamic and antibiotic therapy impair the pathogenesis of Enterococcus faecium in a whole animal insect model. PLoS One 2013 0.89
119 Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro. J Biophotonics 2013 0.88
120 Combination approaches to potentiate immune response after photodynamic therapy for cancer. Photochem Photobiol Sci 2011 0.88
121 Photodynamic therapy using intra-articular Photofrin for murine MRSA arthritis: biphasic light dose response for neutrophil-mediated antibacterial effect. Lasers Surg Med 2011 0.88
122 Antimicrobial photodynamic therapy with RLP068 kills methicillin-resistant Staphylococcus aureus and improves wound healing in a mouse model of infected skin abrasion PDT with RLP068/Cl in infected mouse skin abrasion. J Biophotonics 2012 0.87
123 Effects of 810-nm laser on murine bone-marrow-derived dendritic cells. Photomed Laser Surg 2011 0.87
124 Ultraviolet C light for Acinetobacter baumannii wound infections in mice: potential use for battlefield wound decontamination? J Trauma Acute Care Surg 2012 0.87
125 Stable synthetic bacteriochlorins for photodynamic therapy: role of dicyano peripheral groups, central metal substitution (2H, Zn, Pd), and Cremophor EL delivery. ChemMedChem 2012 0.87
126 Bioconjugatable porphyrins bearing a compact swallowtail motif for water solubility. Bioconjug Chem 2006 0.87
127 Surface modification of a polyhedral oligomeric silsesquioxane poly(carbonate-urea) urethane (POSS-PCU) nanocomposite polymer as a stent coating for enhanced capture of endothelial progenitor cells. Biointerphases 2013 0.86
128 Melanoma resistance to photodynamic therapy: new insights. Biol Chem 2013 0.86
129 Intravascular detection of inflamed atherosclerotic plaques using a fluorescent photosensitizer targeted to the scavenger receptor. Photochem Photobiol Sci 2007 0.86
130 Photodynamic therapy can induce a protective innate immune response against murine bacterial arthritis via neutrophil accumulation. PLoS One 2012 0.86
131 The immunosuppressive side of PDT. Photochem Photobiol Sci 2011 0.86
132 Thiocyanate potentiates antimicrobial photodynamic therapy: in situ generation of the sulfur trioxide radical anion by singlet oxygen. Free Radic Biol Med 2013 0.86
133 Effects of photodynamic therapy on Gram-positive and Gram-negative bacterial biofilms by bioluminescence imaging and scanning electron microscopic analysis. Photomed Laser Surg 2013 0.86
134 Low-level laser therapy can produce increased aggressiveness of dysplastic and oral cancer cell lines by modulation of Akt/mTOR signaling pathway. J Biophotonics 2013 0.86
135 Pulsed electric fields for burn wound disinfection in a murine model. J Burn Care Res 2015 0.85
136 UVC light prophylaxis for cutaneous wound infections in mice. Antimicrob Agents Chemother 2012 0.85
137 Ultraviolet-C irradiation for prevention of central venous catheter-related infections: an in vitro study. Photochem Photobiol 2010 0.85
138 Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C₇₀ and C₈₄O₂ Fullerene Derivatives. Nanomedicine 2012 0.85
139 Combination ALA-PDT and ablative fractional Er:YAG laser (2,940 nm) on the treatment of severe acne. Lasers Surg Med 2014 0.85
140 Cationic porphycenes as potential photosensitizers for antimicrobial photodynamic therapy. J Med Chem 2010 0.84
141 Potentiation of antimicrobial photodynamic inactivation mediated by a cationic fullerene by added iodide: in vitro and in vivo studies. Nanomedicine (Lond) 2015 0.84
142 Selective photoinactivation of Candida albicans in the non-vertebrate host infection model Galleria mellonella. BMC Microbiol 2013 0.83
143 Photosensitizer delivery to vulnerable atherosclerotic plaque: comparison of macrophage-targeted conjugate versus free chlorin(e6). J Biomed Opt 2006 0.83
144 Analysis of the bacterial heat shock response to photodynamic therapy-mediated oxidative stress. Photochem Photobiol 2011 0.83
145 Carbon nanotubes part I: preparation of a novel and versatile drug-delivery vehicle. Expert Opin Drug Deliv 2015 0.83
146 CpG oligodeoxynucleotide as immune adjuvant enhances photodynamic therapy response in murine metastatic breast cancer. J Biophotonics 2013 0.83
147 Low-level laser therapy for spinal cord injury in rats: effects of polarization. J Biomed Opt 2013 0.83
148 Muscular pre-conditioning using light-emitting diode therapy (LEDT) for high-intensity exercise: a randomized double-blind placebo-controlled trial with a single elite runner. Physiother Theory Pract 2015 0.83
149 Antimicrobial photodynamic inactivation inhibits Candida albicans virulence factors and reduces in vivo pathogenicity. Antimicrob Agents Chemother 2012 0.83
150 Photodynamic therapy induces an immune response against a bacterial pathogen. Expert Rev Clin Immunol 2012 0.82
151 Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro. Mycopathologia 2014 0.82
152 Shining light on nanotechnology to help repair and regeneration. Biotechnol Adv 2012 0.82
153 Disruptive innovations: new anti-infectives in the age of resistance. Curr Opin Pharmacol 2013 0.82
154 Time response of increases in ATP and muscle resistance to fatigue after low-level laser (light) therapy (LLLT) in mice. Lasers Med Sci 2015 0.81
155 Channelrhodopsins: visual regeneration and neural activation by a light switch. N Biotechnol 2013 0.81
156 Macrophage-targeted photosensitizer conjugate delivered by intratumoral injection. Mol Pharm 2006 0.81
157 Photodynamic inactivation of biofilm: taking a lightly colored approach to stubborn infection. Expert Rev Anti Infect Ther 2013 0.81
158 Synthesis of decacationic [60]fullerene decaiodides giving photoinduced production of superoxide radicals and effective PDT-mediation on antimicrobial photoinactivation. Eur J Med Chem 2013 0.81
159 Eradication of multidrug-resistant A. baumannii in burn wounds by antiseptic pulsed electric field. Technology (Singap World Sci) 2014 0.81
160 Functionalized fullerenes in photodynamic therapy. J Biomed Nanotechnol 2014 0.81
161 Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: in vitro and in vivo studies. Nanomedicine (Lond) 2013 0.81
162 Delivery of ribosome-inactivating protein toxin into cancer cells with shock waves. Cancer Lett 2003 0.80
163 Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy. ChemMedChem 2010 0.80
164 Potentiation of photoinactivation of Gram-positive and Gram-negative bacteria mediated by six phenothiazinium dyes by addition of azide ion. Photochem Photobiol Sci 2014 0.80
165 Low-level laser therapy (LLLT) combined with swimming training improved the lipid profile in rats fed with high-fat diet. Lasers Med Sci 2012 0.80
166 Synthesis and characterization of positively charged pentacationic [60]fullerene monoadducts for antimicrobial photodynamic inactivation. Molecules 2012 0.80
167 Animal models of skin disease for drug discovery. Expert Opin Drug Discov 2013 0.79
168 Photodynamic Therapy for Cancer and for Infections: What Is the Difference? Isr J Chem 2012 0.79
169 Low intensity laser therapy accelerates muscle regeneration in aged rats. Photonics Lasers Med 2012 0.79
170 Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy. Bioanalysis 2013 0.79
171 Molecular electronic tuning of photosensitizers to enhance photodynamic therapy: synthetic dicyanobacteriochlorins as a case study. Photochem Photobiol 2013 0.79
172 Antimicrobial mechanisms behind photodynamic effect in the presence of hydrogen peroxide. Photochem Photobiol Sci 2010 0.79
173 Carbon nanotubes part II: a remarkable carrier for drug and gene delivery. Expert Opin Drug Deliv 2015 0.79
174 Characterization of a conjugate between Rose Bengal and chitosan for targeted antibiofilm and tissue stabilization effects as a potential treatment of infected dentin. Antimicrob Agents Chemother 2012 0.79
175 Photonic real-time monitoring of bacterial reduction in root canals by genetically engineered bacteria after chemomechanical endodontic therapy. Braz Dent J 2007 0.79
176 Effect of virulence factors on the photodynamic inactivation of Cryptococcus neoformans. PLoS One 2013 0.79
177 Therapeutic options and emerging alternatives for multidrug resistant staphylococcal infections. Curr Pharm Des 2015 0.79
178 Healing of perforating rat corneal incisions closed with photodynamic laser-activated tissue glue. Lasers Surg Med 2004 0.79
179 Can osteoarthritis be treated with light? Arthritis Res Ther 2013 0.78
180 Synthesis and evaluation of cationic bacteriochlorin amphiphiles with effective in vitro photodynamic activity against cancer cells at low nanomolar concentration. J Porphyr Phthalocyanines 2013 0.78
181 Chitosan dressing promotes healing in third degree burns in mice: gene expression analysis shows biphasic effects for rapid tissue regeneration and decreased fibrotic signaling. J Biomed Mater Res A 2012 0.78
182 Cellular and vascular effects of the photodynamic agent temocene are modulated by the delivery vehicle. J Control Release 2012 0.78
183 The impact of macrophage-cancer cell interaction on the efficacy of photodynamic therapy. Photochem Photobiol Sci 2015 0.78
184 Photodynamic inactivation of bacteria using polyethylenimine-chlorin(e6) conjugates: Effect of polymer molecular weight, substitution ratio of chlorin(e6) and pH. Lasers Surg Med 2011 0.78
185 Photodynamic therapy with hyperbranched poly(ether-ester) chlorin(e6) nanoparticles on human tongue carcinoma CAL-27 cells. Photodiagnosis Photodyn Ther 2011 0.77
186 Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis. Photochem Photobiol 2013 0.77
187 Antimicrobial photodynamic therapy and photodynamic inactivation, or killing bugs with dyes and light--a symposium-in-print. Photochem Photobiol 2012 0.76
188 Electroporation enhances antimicrobial photodynamic therapy mediated by the hydrophobic photosensitizer, hypericin. Photodiagnosis Photodyn Ther 2013 0.76
189 Cutaneous sporotrichosis treated with photodynamic therapy: an in vitro and in vivo study. Photomed Laser Surg 2013 0.76
190 Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness: Case-control Study with a Pair of Identical Twins. Am J Phys Med Rehabil 2016 0.76
191 Killing bacterial spores with blue light: when innate resistance meets the power of light. Photochem Photobiol 2012 0.76
192 Photodynamic therapy: one step ahead with self-assembled nanoparticles. J Biomed Nanotechnol 2014 0.76
193 Multi-Functionality in Theranostic Nanoparticles: is more Always Better? J Nanomed Nanotechnol 2012 0.76
194 Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov 2015 0.75
195 Antimicrobial photodynamic therapy in the colon: delivering a light punch to the guts? Photochem Photobiol 2011 0.75
196 Gram-negative bacterial infection in thigh abscess can migrate to distant burn depending on burn depth. Interdiscip Perspect Infect Dis 2012 0.75
197 Linear and Nonlinear Optical Properties of Photoresponsive [60]Fullerene Hybrid Triads and Tetrads with Dual NIR Two-Photon Absorption Characteristics. J Phys Chem C Nanomater Interfaces 2013 0.75
198 Dye-enhanced multimodal confocal microscopy for noninvasive detection of skin cancers in mouse models. J Biomed Opt 2010 0.75
199 Synthesis of photoresponsive dual NIR two-photon absorptive [60]fullerene triads and tetrads. Molecules 2013 0.75
200 Photodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In Vivo. J Nanosci Nanotechnol 2016 0.75
201 Distinctive features of foreskin condylomata acuminata associated with diabetes mellitus. Acta Derm Venereol 2008 0.75
202 Surface layer-preserving photodynamic therapy (SPPDT) in a subcutaneous mouse model of lung cancer. Lasers Surg Med 2012 0.75
203 Facial Manifestations of Pachydermoperiostosis Treated with Botulinum Toxin Type-A: Report of 3 Cases. Acta Derm Venereol 2017 0.75
204 Reply to the Letter to the Editor on "Effects of Light-Emitting Diode Therapy on Muscle Hypertrophy, Gene Expression, Performance, Damage, and Delayed-Onset Muscle Soreness: Case-Control Study With a Pair of Identical Twins". Am J Phys Med Rehabil 2017 0.75
205 Exploration of Copper-Cysteamine Nanoparticles as a New Type of Agents for Antimicrobial Photodynamic Inactivation. J Biomed Nanotechnol 2019 0.75